NCT01510392

CEI Van Outreach Screening Study

Prospective Evaluation of Optical Coherence Tomography Usage in the Screening of Eye Diseases

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 118 (actual)
• Sponsor: Oregon Health and Science University · Academic / Other
• Sex: All
• Age: 18 Years – 89 Years
• Healthy volunteers: Accepted

Summary

The primary goal of the trial is to show that optical coherence tomography (OCT) technology can be used to effectively screen for diseases of the eye including glaucoma, macular diseases and keratoconus. Glaucoma is a disease that causes permanent vision loss and is usually accompanied by increased eye pressure. Macular diseases affect sharp, central vision. Keratoconus is a disease that affects the cornea (clear surface covering the colored part of the eye).

Detailed description

The identification of many eye diseases would significantly benefit from earlier detection than is available with typical eye exams. Optical coherence tomography (OCT) is an imaging technology that can perform non-contact cross-sectional imaging of tissue structure in real time. It is similar to ultrasound B-mode imaging, except that OCT measures the intensity of reflected light rather than sound waves.

Conditions

• Glaucoma
• Macular Disease
• Keratoconus

Interventions

Type	Name	Description
DEVICE	OCT imaging, the FDA Cleared iVue	The OCT system scans a beam of light across the eye to take a picture. OCT imaging does not touch the eye. This is a test that is performed using an FDA approved system, and is regularly used to take pictures of the back of the eye.

Timeline

• Start date: 2012-01-01
• Primary completion: 2017-02-02
• Completion: 2017-02-02
• First posted: 2012-01-16
• Last updated: 2018-04-12

Locations

1 site across 1 country: United States